Related Experiment Videos
Tumor treatment and cytokines
J W Schrader1, K B Leslie, P Orban
1Biomedical Research Centre, UBC., Vancouver, Canada.
Progress in Clinical and Biological Research
|January 1, 1990
Summary
Cytokines, signaling molecules released by the body, show promise in cancer therapy by boosting immune responses. While direct tumor cell killing is challenging, their use alongside conventional treatments like chemotherapy is a key area of research.
Area of Science:
- Immunology and Molecular Biology
- Biochemistry and Cell Biology
Background:
- Cytokines are signaling proteins crucial for regulating cellular responses to injury and invasion.
- Advances in molecular biology and biochemical techniques have enabled rapid characterization of numerous cytokines.
- Many cytokines are currently in clinical trials for their therapeutic potential.
Purpose of the Study:
- To review the role of cytokines in the body's defense and repair mechanisms.
- To explore the therapeutic applications of cytokines in cancer treatment.
- To discuss the potential of cytokine-based therapies as adjuncts to conventional cancer treatments.
Main Methods:
- Literature review and synthesis of current research on cytokine biology and applications.
- Analysis of clinical trial data for cytokine-based therapeutics.
- Discussion of the mechanisms by which cytokines modulate immune and cellular functions.
Main Results:
- Cytokines effectively regulate a wide range of cell types involved in defense and repair.
- While direct tumoricidal effects of cytokines are limited, their ability to modulate immune responses is significant.
- Hemopoietic growth factors, IL-1, and IL-6 show promise in enhancing conventional cancer therapies.
Conclusions:
- Cytokines hold significant potential as adjunctive therapies in cancer treatment, particularly by stimulating immune defense mechanisms.
- Future research may focus on cytokine antagonists for targeted therapy against tumors and their microenvironment.
- The para-physiological application of cytokines, especially hemopoietic growth factors, represents a promising strategy in oncology.